The current prospective clinical study's aim is to determine ABT's ICE implant survival rate, crestal interproximal bone resorption during 24 months post implant insertion and to assimilate the drilling sequence during the clinical use of ICE implants.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
35
ICE- Implant Classical Esthetic implant
Assaf Harofeh Medical Center
Rishon LeZiyyon, Israel
Cumulative Survival Rate
Time frame: 24 MONTHS
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.